Dr. Antin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
# Dana-Far
Boston, MA 02115Phone+1 617-632-3667Fax+1 617-632-5175
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1981 - 1983
- Brigham and Women's HospitalResidency, Internal Medicine, 1978 - 1981
- Weill Cornell MedicineClass of 1978
Certifications & Licensure
- MA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Boston Herald Castle Connolly, 2005
- Join now to see all
Clinical Trials
- Blood and Marrow Transplant Clinical Research Network Start of enrollment: 2001 Sep 01
- Phase I Study of Sequential Cord Blood Transplants Start of enrollment: 2003 May 01
- Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 62 citationsImpaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide.Benedetta Rambaldi, Haesook T. Kim, Carol Reynolds, Sharmila Chamling Rai, Yohei Arihara
Blood Advances. 2021-01-26 - 16 citationsCharacteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.Rima M Saliba, Amin M Alousi, Joseph Pidala, Mukta Arora, Stephen R Spellman
Transplantation and Cellular Therapy. 2022-10-01 - 122 citationsSirolimus and Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell TransplantationCorey Cutler, N. Lynn Henry, Colm C. Magee, Shuli Li, Haesook T. Kim
Biology of Blood and Marrow Transplantation. 2005-07-01
Journal Articles
- Small-Molecule BCL6 Inhibitor Effectively Treats Mice with Non-Sclerodermatous Chronic Graft-Versus-Host DiseaseJoseph H Antin, Bruce Blazar, Leo Luznik, John Koreth, Ivan Maillard, Robert J Soiffer, James E Bradner, Jonathan S Serody, Jerome Ritz, Blood
Abstracts/Posters
- Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...Joseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Anti-CD6 Monoclonal Antibody Itolizumab Efficiently Inhibits T Cell Proliferation after in Vitro TCR Stimulation in the Setting of Acute Graft Versus Host DiseaseJoseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Pr...Joseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- ASBMT NewsOctober 13th, 2018
- Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 9th, 2017
- Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 8th, 2017
- Join now to see all
Grant Support
- A Randomized Trial Of Tac/Mtx/Bortezomib VS Tac/Mtxplacebo In Allogeneic HSCTNational Heart, Lung, And Blood Institute2011
- Novel Approaches To Graft-Versus-Host Disease PreventionNational Cancer Institute2009–2011
- Mechanisms Of GVHDNational Cancer Institute2009–2011
- Administrative CoreNational Cancer Institute2009–2011
- Random Trial Of CD8 T-Cell Depletion In PBSC TransplantationNational Heart, Lung, And Blood Institute2006–2010
- Novel Approaches To Ghvd PreventionNational Heart, Lung, And Blood Institute2007
- Mechanisms Of GVHDNational Heart, Lung, And Blood Institute2003–2007
- Randomized Trial Of CD8 T-Cell Depletion In PBSC Transp*National Heart, Lung, And Blood Institute2001–2005
- Use Of Unrelated Donors For Bone Marrow TransplantationNational Center For Research Resources1997–1999
- Phlebotomy For Research Studies After Marrow TransplantationNational Center For Research Resources1997–1999
- Core--Clinical Bone Marrow Transplant ProgramNational Cancer Institute1997
- Novel Therapy For Chronic Myelogenous LeukemiaNational Cancer Institute1993–1996
Professional Memberships
- Member
- American Society of Blood and Marrow TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: